Drugs / Tetanus and Diphtheria Toxoids Adsorbed
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03589768 Comparator | Jan 2019 → Jul 2020 | Clostridium difficile colitis, diphtheria, pertussis, tetanus | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus and Diphtheria Toxoids Adsorbed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03589768 ↗ |
| Modality | Vaccine | “tetanus and diphtheria vaccine (Td) vaccine” PMID 38586589 ↗ Mar 2024 |
| Route | Intramuscular | “0.5 ml single dose of Td (Tetanus, Diphtheria Toxoid) administered intramuscularly to pregnant women” NCT03589768 ↗ |